Advertisement

Topics

Is BMS The Must Have Immuno-Oncology Accessory Of The Season?

07:44 EDT 19 Jun 2017 | SCRIP

Bristol-Myers Squibb is in the M&A hot seat according to analysts from Bernstein, and Pfizer could be the one applying...

      

Related Stories

 

Original Article: Is BMS The Must Have Immuno-Oncology Accessory Of The Season?

NEXT ARTICLE

More From BioPortfolio on "Is BMS The Must Have Immuno-Oncology Accessory Of The Season?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...